About Ben Wolin
Form D filings for Aerami Therapeutics from 2019 to 2020 list Ben Wolin as director.
Ben Wolin first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Ben Wolin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ben Wolin works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D, Jun 17, 2020
KJ
Kenneth Lee, Jr.
Director
TC
Timm Crowder
Executive officer
AW
Anne Whitaker
Executive officer and director
BW
Bill Welch
Director
ST
Steve Thornton
Director
MK
Michael Kaseta
Chief Financial Officer
JP
John Patton
Director
AS
Adam Stern
Director